<a href="https://laohu8.com/S/CABA">Cabaletta Bio</a> Inc. Announces Repricing of Stock Options to Retain and Motivate Employees
Cabaletta Bio Inc. has announced a repricing of stock options for current employees, directors, and key consultants, effective May 19, 2025. The repricing affects options granted under the company's 2018 and 2019 Stock Option Plans, specifically targeting those with exercise prices exceeding 1.5 times the company's common stock closing price on the Nasdaq Global Select Market as of the effective date. The new exercise price for eligible options is set at $1.92. To benefit from the reduced exercise price, participants must remain with the company through a defined retention period, which concludes either on May 19, 2026, upon a sale event, or due to the participant's death or disability. The board approved this measure after careful deliberation, aiming to address the fact that approximately 75% of stock options were previously "underwater."
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cabaletta Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-074589), on May 19, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。